Annual report pursuant to Section 13 and 15(d)

Description of Business and Summary of Significant Accounting Policies - Restructuring Charges (Details)

Description of Business and Summary of Significant Accounting Policies - Restructuring Charges (Details) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2023	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021
Restructuring costs							$ 3,829	$ 1,640	$ 142
Restructuring reserves, Ending Balance	$ 0					$ 0	0
Protein Sciences \| QT Holdings Corporation
Restructuring costs			$ 2,170
Cash payments						(2,005)
Adjustments						(165)
Diagnostics and Genomics
Restructuring costs					$ 1,185			242
Cash payments								(1,143)
Adjustments								(284)
Selling, General and Administrative Expenses [Member] \| Protein Sciences \| QT Holdings Corporation
Restructuring costs							2,170
Selling, General and Administrative Expenses [Member] \| Diagnostics and Genomics
Restructuring costs								1,399
Employee Severance [Member] \| Protein Sciences
Restructuring costs	897	$ 780
Cash payments	(762)
Adjustments	(18)
Accrued restructuring actions balances	$ 897					897	897
Employee Severance [Member] \| Protein Sciences \| QT Holdings Corporation
Restructuring costs			1,328
Cash payments						(1,233)
Adjustments						(95)
Employee Severance [Member] \| Diagnostics and Genomics
Restructuring costs					639
Cash payments								(589)
Adjustments								(50)
Employee Severance [Member] \| Selling, General and Administrative Expenses [Member] \| Protein Sciences \| QT Holdings Corporation
Restructuring costs							1,328
Employee Severance [Member] \| Selling, General and Administrative Expenses [Member] \| Diagnostics and Genomics
Restructuring costs								649
Employee Severance on Relocation of US Plant [Member]
Restructuring costs				$ 200
Asset Impairment and Other [Member] \| Protein Sciences \| QT Holdings Corporation
Restructuring costs			$ 842
Cash payments						(772)
Adjustments						$ (70)
Asset Impairment and Other [Member] \| Diagnostics and Genomics
Restructuring costs					$ 546			242
Cash payments								(554)
Adjustments								(234)
Asset Impairment and Other [Member] \| Selling, General and Administrative Expenses [Member] \| Protein Sciences \| QT Holdings Corporation
Restructuring costs							$ 842
Asset Impairment and Other [Member] \| Selling, General and Administrative Expenses [Member] \| Diagnostics and Genomics
Restructuring costs								$ 750